When CDK12/13 stalls, healthy prostate cells take a malignant turn

CDK12 is established as a tumor suppressor in prostate cancer, with its loss driving aggressive disease and creating vulnerabilities for targeted therapies.

How a Kamala Harris presidency would change health care, from drug pricing to abortion

WASHINGTON — If Vice President Harris wins the presidency, in many ways, she’ll work to achieve health care ideas that Democrats couldn’t quite push across

October 24, 2024

Navigating clinical trial disruption: growing trends and new technologies – Pharmaceutical Technology

The clinical trial landscape is changing. What do organisers need to know to navigate potential disruption? Source: Shutterstock. Disruption is a pressing problem in the

October 22, 2024

Enhanced Gene Therapy Patent Filed by Selecta Biosciences

Share this article According to GlobalData’s company profile on Selecta Biosciences, Nanoparticle drug conjugates was a key innovation area identified from patents. Selecta Biosciences‘s grant

March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.